Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis

EUROPEAN JOURNAL OF HAEMATOLOGY

Fric, D; Stork, M; Boichuk, I; Sandecka, V; Adam, Z; Krejci, M; Ondrouskova, E; Fidrichova, A; Radova, L; Knechtova, Z; Jarosova, M; Pour, L, 2024: Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis. EUROPEAN JOURNAL OF HAEMATOLOGY 113(6), doi: 10.1111/ejh.14292

Research Groups:

Medical Genomics

CEITEC authors:

Lenka Radová, Ph.D.